Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090541 | SCV001246146 | pathogenic | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001195875 | SCV001366299 | likely pathogenic | KBG syndrome | 2018-11-30 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2. |
Ambry Genetics | RCV001266682 | SCV001444859 | pathogenic | Inborn genetic diseases | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Department of Genetics, |
RCV003127628 | SCV003803760 | pathogenic | Developmental disorder | 2020-08-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001090541 | SCV004168933 | pathogenic | not provided | 2023-04-26 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32124548, 34971082, 31703437) |